Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients

Transpl Int. 1996;9(3):221-6. doi: 10.1007/BF00335389.

Abstract

Fasting plasma cholesterol, triglycerides, high-density lipoprotein (HDL) and apoprotein (apo) B were elevated in 214 nondiabetic renal transplant recipients when compared to a reference group. Apo (a) was slightly but not significantly lower in transplant recipients (median 118 mg/dl, range 16-1680 vs 130 mg/dl, 10-1176) and this difference could be predicted from Lp (a) isoform analysis. Cholesterol, triglyceride, apo B and apo (a) concentrations correlated negatively with creatinine clearance but none of these parameters showed a significant association with proteinuria. Patients treated with steroids had higher plasma HDL concentrations than those receiving cyclosporin monotherapy (P < 0.01). The use of diuretics was associated with raised triglycerides (P < 0.001) and cholesterol (P < 0.01) and with reduced HDL (P < 0.01) whilst patients receiving beta-blockers had significantly higher triglycerides (P < 0.01) and lower HDL levels (P < 0.02). In multiple regression analysis, age (P < 0.01), creatinine clearance (P < 0.05) and diuretic therapy (P < 0.005) were independent risk factors for increased cholesterol whilst apo (a) levels correlated negatively with creatinine clearance (P < 0.005). These results suggest that impaired renal function, steroids and non-immunosuppressive drugs contribute to lipid abnormalites in renal transplant recipients.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Apolipoprotein A-I / blood
  • Apolipoproteins / blood*
  • Apolipoproteins / genetics
  • Apolipoproteins B / blood
  • Apoprotein(a)
  • Cholesterol / blood*
  • Creatinine / blood
  • Cyclosporine / therapeutic use
  • Diuretics / therapeutic use
  • Female
  • Humans
  • Hyperlipidemias / epidemiology
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / physiology*
  • Lipoprotein(a)*
  • Lipoproteins / blood*
  • Lipoproteins, HDL / blood
  • Lipoproteins, LDL / blood
  • Male
  • Phenotype
  • Prednisolone / therapeutic use
  • Regression Analysis
  • Risk Factors
  • Triglycerides / blood*

Substances

  • Adrenergic beta-Antagonists
  • Apolipoprotein A-I
  • Apolipoproteins
  • Apolipoproteins B
  • Diuretics
  • Immunosuppressive Agents
  • Lipoprotein(a)
  • Lipoproteins
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Triglycerides
  • Cyclosporine
  • Cholesterol
  • Prednisolone
  • Creatinine
  • Apoprotein(a)